Smith & Nephew (SNN) Long-Term Debt Issuances (2009 - 2018)
Smith & Nephew (SNN) posted quarterly Long-Term Debt Issuances of -$1.3 billion for Q4 2018, up 8.57% year-on-year from -$1.2 billion in Q4 2017, and up 8.57% on a QoQ basis from -$1.4 billion in Q4 2017.
Smith & Nephew (SNN) Long-Term Debt Issuances (2009 - 2018) Analysis & Trends
Smith & Nephew (SNN) has reported Long-Term Debt Issuances for 9 consecutive years, with -$1.3 billion the latest figure, recorded in Q4 2018.
- Quarterly Long-Term Debt Issuances rose 8.57% year-over-year to -$1.3 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$5.7 billion (up 3.88% YoY) and the FY2024 annual result came in at $1.0 billion, changed N/A from the prior year.
- Long-Term Debt Issuances grew to -$1.3 billion in Q4 2018 per SNN's latest filing, from -$1.4 billion in the prior quarter.
- Over the last five years, Long-Term Debt Issuances for SNN reached as high as $5.3 billion in Q4 2014 and fell as low as -$1.6 billion in Q4 2016.
- A 5-year average of -$268.3 million and a median of -$1.4 billion in 2017 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2014 — Long-Term Debt Issuances jumped 1634.87% — and 2015, when it slumped 126.92%.
- Year by year, Long-Term Debt Issuances stood at $5.3 billion in 2014, then sank by 126.92% to -$1.4 billion in 2015, then declined by 9.07% to -$1.6 billion in 2016, then increased by 9.02% to -$1.4 billion in 2017, then climbed by 8.57% to -$1.3 billion in 2018.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$1.3 billion, -$1.4 billion, and -$1.6 billion for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.71 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.30 Bn |
| Dec 31, 2018 | -1.30 Bn |
| Dec 31, 2017 | -1.42 Bn |
| Dec 31, 2017 | -1.42 Bn |
| Dec 31, 2016 | -1.56 Bn |
| Dec 31, 2016 | -1.56 Bn |
| Dec 31, 2015 | -1.43 Bn |
| Dec 31, 2015 | -1.43 Bn |
| Jun 30, 2015 | -1.53 Bn |
| Jun 30, 2015 | -1.53 Bn |
| Dec 31, 2014 | 5.33 Bn |
| Dec 31, 2014 | 5.33 Bn |
| Sep 30, 2014 | 50.00 Mn |
| Sep 30, 2014 | 50.00 Mn |
| Dec 31, 2013 | -347.00 Mn |
| Dec 31, 2013 | -347.00 Mn |
| Sep 28, 2013 | -289.00 Mn |
| Sep 28, 2013 | -289.00 Mn |
| Jun 29, 2013 | -335.00 Mn |
| Jun 29, 2013 | -335.00 Mn |